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The murine cytomegalovirus (MCMV) M44 gene product pp50 is normally present in the nuclei of virus-infected cells.
During transient expression of pp50 in COS-1 cells, the phosphoprotein was readily detectable in the nuclei, indicating that
it possesses a nuclear localization signal (NLS). Studies on the subcellular locations of N- and C-terminal deletion mutants
of pp50 suggested that alterations in both the C terminus and the highly conserved N-terminal domains of pp50 affect nuclear
localization. In particular, the C-terminal 11 amino acids of pp50, which includes a ‘‘KKQK’’ motif, were able to mediate the
import of a b-galactosidase fusion protein into the nucleus. The pair of lysine residues in this motif constitutes an essential
element of the C-terminal NLS as mutation of this motif to AAQK directly affected the nuclear localization of either pp50 or
b-galactosidase fusion proteins containing the C-terminal portion of pp50. Furthermore our results indicated that the
functionality of the C-terminal NLS is dependent on the structural integrity of the highly conserved N-terminal portion of the
molecule, as deletion of amino acids 157–201 alone adversely affected nuclear localization. In the absence of a functional
C-terminal NLS, the subcellular localization of pp50 is sensitive to potential conformational changes induced by mutations
within the N-terminal half of the molecule. Under those circumstances, mutation of the YK residues at position 22–23 or
deletion of amino acids 267–283 was sufficient to produce a protein that was impaired in nuclear import or retention. © 1999
Academic Press
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dINTRODUCTION
The transport of functional proteins to appropriate
ompartments within the cell is an important regulatory
echanism of cellular processes in eucaryotic organ-
sms. For example, surface glycoproteins are sorted
hrough the endoplasmic reticulum–Golgi pathway on
heir way to the cell surface, whereas transcription fac-
ors and DNA replication enzymes are translocated into
he nucleus. In recent years, significant progress has
een made in the identification of factors involved in
uclear import (Go¨rlich, 1997). Within a cell, a nuclear
nvelope forms a barrier to passive diffusion between
he nucleoplasm and the cytoplasm, and cytosolic pro-
eins larger than ;60,000 can only be actively trans-
orted into the nucleus if they possess a nuclear local-
zation signal (Dingwall and Laskey, 1986). Thus cellular
roteins like the tumor suppressor p53 (Shaulsky et al.,
991) or the glucocorticoid receptor (Picard and
amamoto, 1987), which are functionally dependent on
heir translocation into the nucleus, possess nuclear
ocalization signals within their coding sequence to en-
ure targeting to the proper cellular compartment. The
1 To whom reprint requests should be addressed. Fax: (306) 966-
c311. E-mail: loh@sask.usask.ca.
43ecent development of an in vitro nuclear import assay
Adam et al., 1990) has facilitated the identification of
everal cellular proteins essential for mediating nuclear
ransport (Adam and Gerace, 1991; Go¨rlich et al., 1994),
eading to a better understanding of the molecular mech-
nisms underlying this process.
Two distinct pathways for nuclear import have been
dentified. The more recently characterized M9 domain of
8 amino acids (Siomi and Dreyfuss, 1995), present in a
ubset of hnRNP (heterogeneous nuclear RNA-binding
roteins), mediates nuclear import via transportin, a M9-
pecific receptor (Pollard et al., 1996). In contrast, the
‘classical’’ nuclear localization signal (NLS), which medi-
tes nuclear import of the vast majority of nuclear pro-
eins via the importin-dependent pathway (Go¨rlich and
attaj, 1996; Go¨rlich, 1997), has no clear consensus
equence. Instead it is characterized by the presence of
lusters of basic amino acids that can be either contin-
ous, like the SV40 T-antigen (Kalderon et al., 1984a,b), or
ipartite, as exemplified by nucleoplasmin (Dingwall et
l., 1988; Robbins et al., 1991). Cytoplasmic proteins
used with functional NLSs can be actively transported
nto the nucleus (Gao and Knipe, 1992; Tillman et al.,
994). However, residues surrounding a NLS or even
istal sequences can affect its function, perhaps be-
ause of the need for such sequences to be exposed on
0042-6822/99 $30.00
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44 LOH, KEELER, AND SHANLEYhe surface of a protein (Roberts et al., 1987; Gao and
nipe, 1992; Yao et al., 1995). It has also been demon-
trated that the rate of import could be influenced by
hosphorylation of nearby casein kinase II sites (Rihs et
l., 1991). Alternatively, proteins lacking a NLS can asso-
iate with one possessing a NLS, thereby gaining entry
nto the nucleus (Shaulsky et al., 1990).
The murine cytomegalovirus phosphoprotein pp50, en-
oded by the M44 open reading frame (ORF), consists of
11 amino acids and is the homolog of the human cyto-
egalovirus (HCMV) polymerase accessory protein
pUL44 (Loh et al., 1991, 1994; Pande et al., 1991; Raw-
inson et al., 1996). The M44 ORF shares extensive se-
uence homology with its HCMV and human herpesvirus
ype 6 (HHV-6) homologs, with the greatest sequence
onservation found within the N-terminal two-thirds of
he molecule. The four regions with the highest degree of
onservation between the three viruses are delineated
y blocks in Fig. 1, with Regions 1 and 2 located within
he N-terminal two-thirds of pp50, and the smaller Re-
ions 3 and 4 located at the C-terminal end of the
olecule. Although pp50 and the herpes simplex virus
ype 1 (HSV-1) UL42 gene product share almost no amino
cid sequence homology, the two proteins are function-
lly analogous. Recent studies have shown that HCMV
pUL44 is a dsDNA-binding protein (Weiland et al., 1994)
ssential for viral DNA replication (Pari and Anders, 1993;
ari et al., 1993; Ripalti et al., 1995). It was localized to the
uclei of virus-infected cells (Plachter et al., 1992) and
timulated the activity of the viral DNA polymerase (Ertl
nd Powell, 1992; Weiland et al., 1994).
As a homolog of HCMV ppUL44, pp50 is predicted to
e required for viral DNA replication, which normally
ccurs in the nucleus. Thus the ability of pp50 to localize
o the nucleus of infected cells is essential for its role in
he virus replication cycle. Our laboratory has previously
emonstrated that pp50 is a DNA-binding protein that
ocalizes to the nuclei of MCMV-infected cells (Loh et al.,
994). Results from size fractionation experiments sug-
ested that pp50 is present predominantly as ho-
odimers or in high molecular weight complexes with
ther viral or cellular proteins (Loh et al., 1994) that are
arger than the 60,000 limit for passive diffusion into the
ucleus, thereby necessitating the presence of a NLS for
uclear localization. During transient expression, pp50
as found to be present exclusively in the nuclei of
ransfected cells (Loh et al., 1994), suggesting that the
rotein possesses a functional nuclear localization sig-
al. Analysis of the M44 ORF revealed a highly con-
erved NLS-like sequence at the C terminus of the pro-
ein. The putative NLS contains a stretch of basic amino
cids ‘‘KKQK’’ (Fig. 7A, first line) and a potential casein
inase II phosphorylation site at the serine residue 15
mino acids upstream. Two additional clusters of basic
mino acids are present between residues 5 and 8 l‘‘RKVR,’’ Fig. 7A, first line) and residues 169–174 (‘‘KRN-
KK,’’ Fig. 7B) either of which could be a potential can-
idate for the NLS of pp50.
In this report, we describe experiments designed to
dentify pp50 sequences involved in nuclear localization.
o this end, pp50 mutants were transiently expressed in
OS-1 cells by transfection of cells with plasmids encod-
ng mutant forms of the protein. The subcellular locations
f pp50 mutants were determined by an indirect immu-
ofluorescence assay using a panel of monoclonal anti-
odies recognizing epitopes located in different seg-
ents of the molecule. This approach allowed us to
xamine the subcellular location of pp50 independent of
iral infection, where association with other viral proteins
ay influence its eventual subcellular localization. We
mployed deletion analysis to identify pp50 sequences
equired for nuclear localization of the protein. Further-
ore chimeric proteins consisting of b-galactosidase
used in frame with putative NLSs were constructed to
valuate whether specific viral sequences were capable
f directing nuclear import of the fusion proteins. Finally
ite-directed mutagenesis was used to identify amino
cids that may affect the nuclear localization of pp50. Our
esults indicate that the pair of lysine residues within the
‘KKQK’’ motif at the extreme C terminus of the protein
onstitutes an essential element of a functional NLS that
ould mediate the active transport of b-galactosidase
nto the nucleus. In addition, the functionality of this NLS
s likely to be dependent on the proper folding of the
onserved N-terminal domains of pp50.
RESULTS
panel of monoclonal antibodies recognizes
pitopes in distinct domains of pp50
To utilize our panel of pp50-specific MAbs to detect
utant pp50 in immunofluorescence or Western-blotting
xperiments, we attempted to map epitopes recognized
y these MAbs to specific segments of the protein. To
his end, plasmid DNA encoding deletion mutants of
p50 were transfected into COS-1 cells which were har-
ested 48 h later. The solubilized proteins were sepa-
ated by SDS–PAGE, immobilized on nitrocellulose filters,
nd probed with our panel of monoclonal antibodies by
estern blotting. Reactivities of MAbs that did not rec-
gnize pp50 determinants by Western blotting were as-
essed by immunoprecipitation and indirect immunoflu-
rescence. Results from experiments on selected MAbs
re summarized in Table 1.
The six MAbs listed in Table 1 were selected for their
eactivities against distinct segments of pp50. Five of
hese six MAbs (with the exception of 9A5) are reactive
n Western blotting, indicating that they recognize linear
pitopes. Briefly, MAb 31E11 is reactive with an epitopeocated within Region 1 (between amino acid residues
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45NUCLEAR LOCALIZATION IN pp50 SEQUENCES02 and 158), whereas MAb 33C7 recognizes an epitope
ithin a region (between amino acid residues 102 and
95) spanning the C-terminal half of Region 1, the N-
erminal portion of Region 2, and the ‘‘linker’’ between
egions 1 and 2. Monoclonal antibody 25G11 is reactive
ith an epitope located in a region (between amino acid
esidues 202 and 296) encompassing most of Region 2
FIG. 1. Summary of pp50 deletion mutants. The first line represents th
onserved blocks of amino acid residues (between MCMV, HCMV and HH
locks. These conserved blocks were referred to as Regions 1–4 in the te
long the entire length of the pp50 ORF. The solid lines underneath depict
n front of or behind each line represent amino acid residues in single letter
r universal translation stop codons to the truncated ORFs. Deletion mutan
f the mutant proteins were determined by indirect immunofluorescence 48
sed for describing the subcellular locations of deletion mutants are: N, nnd sequences beyond its C-terminal end. Monoclonal cntibody 9A5 is unique among the six MAbs in that it is
eactive with pp50 in immunoprecipitation and indirect
mmunofluorescence assays but not in Western blotting.
n addition, reactivity was lost if any deletions were
ntroduced into conserved Region 2. Thus it is likely that
A5 recognizes a conformation-dependent epitope and
an be used to monitor proper protein folding within
reading frame of pp50 and delineates the locations of the four highly
th the appropriate residue numbers either below or above the numbered
tly underneath is a sequence ruler with tick marks every 20 amino acids
d pp50 sequences encoded by our panel of deletion mutants. The letters
added to pp50 sequences as a result of providing translation start codons
abeled as described under Materials and Methods. Subcellular locations
transfecting COS-1 cells with the appropriate plasmids. The abbreviations
C, cytoplasmic.e open
V-6) wi
xt. Direc
truncate
codes
ts are l
h afteronserved Region 2. Last, although MAbs 5H10 and 3B9
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46 LOH, KEELER, AND SHANLEYppeared to react with antigenic determinants located
ithin the same region near the C terminus of pp50, MAb
H10 but not 3B9 recognized an epitope conserved be-
ween MCMV pp50 and HCMV ppUL44 (Loh et al., 1994),
hereby demonstrating their unique specificities. There-
ore with appropriate choices of antibodies, we were
ble to confirm the predicted sizes and expression of all
he pp50 mutants described in this study by Western
lotting (data not shown) and visualize their subcellular
ocations by immunofluorescence microscopy.
ubcellular location of pp50 N-terminal deletion
utants
We reasoned that if the ‘‘KKQK’’ sequence at the C
erminus rather than the two N-terminal clusters of basic
mino acids (residues 5–8 and residues 169–174) is the
ajor determinant for nuclear localization, progressive
-terminal deletions into the pp50 ORF removing the
atter would produce truncated proteins that are still
redominantly localized to the nucleus. Thus our inves-
igation began with the identification of the subcellular
ocations of pp50 N-terminal deletion mutants by indirect
mmunofluorescence using the panel of MAbs described
n Table 1. The structures and observed subcellular lo-
ations of these mutants are summarized in Fig. 1, and
taining patterns of selected mutants are shown in Fig. 2.
In MCMV-infected Balb/3T3 fibroblasts, pp50 was pri-
T
Reactivity of Monoclonal Anti
MAbs 5H10 3B9
-terminal deletions
dC158 2 2
dC195 2 2
dC236 2 2
dC266 2 2
dC280 2 2
dC296 2 2
dC319 2 2
dC350 2 2
dC367 1 1
dC378 1 1
dC395 1 1
-terminal deletions
dN27 1 1
dN53 1 1
dN83 1 1
dN102 1 1
dN145 1 1
dN171 1 1
dN202 1 1
nternal deletions
d157-201 1 1
d267-283 1 1arily localized to specific compartments of the nucleus sFig. 2A). However, during transient expression of pp50 in
OS-1 cells, the protein is distributed either in a diffuse
anner throughout the nucleus or in a granular pattern
ithin the nucleus (Fig. 2B). The subcellular staining
attern of two of these mutants (dN27 and dN202), some-
hing that is fairly representative of all the N-terminal
eletion mutants examined, is shown in Figs. 2C and 2D.
s illustrated in Fig. 1, Region 1 is progressively deleted
n dN27, dN53, and dN102 until it is completely removed
n dN202. In dN221, Region 1 and part of Region 2 are
eleted. However, similar granular staining patterns in
he nucleus were observed with all these mutants. Thus
rogressive deletion of Regions 1 and 2 along with the
wo aforementioned clusters of basic amino acids from
p50 does not appear to affect the subcellular localiza-
ion of pp50 mutants, suggesting that a nuclear localiza-
ion signal capable of directing the truncated protein to
he nucleus is likely located within the C-terminal half of
p50. This was confirmed by the observation that re-
oval of the last 16 amino acids of pp50 from either
N27 or dN202 completely abolished nuclear localiza-
ion (mutants pp50[27–395] and pp50[202–395] in Figs.
E and 2F).
equences at the extreme C terminus of pp50 can
unction as a NLS
One of the characteristics of a nuclear localization
with pp50 Deletion Mutants
25G11 9A5 33C7 31E11
2 2 2 1
2 2 1 1
2 2 1 1
2 2 1 1
2 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 2 2
1 2 2 2
1 2 2 2
1 2 2 1
1 2 2 1ABLE 1
bodiesignal is its ability to direct the import of a normally
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47NUCLEAR LOCALIZATION IN pp50 SEQUENCESytoplasm-resident protein into the nucleus. To test
hether such a signal sequence exists within the C-
erminal half of pp50, chimeric proteins consisting of
-galactosidase fused in frame with pp50 sequences
ere constructed as described under Materials and
ethods and illustrated in Fig. 3. The subcellular loca-
ions of the chimeric proteins were determined in immu-
ofluorescence experiments, and similar staining pat-
erns were observed using either b-galactosidase spe-
ific or pp50-specific monoclonal antibodies. The
redicted sizes of the fusion proteins were verified by
estern blotting using the same antibodies (data not
hown). The results of these experiments are summa-
ized in Fig. 3, right.
As expected, b-galactosidase was predominantly
resent in the cytoplasm of COS-1 cells transfected with
he b-galactosidase expressing plasmid pSVbgal (Fig.
A). In contrast, the chimeric protein encoded by
SVbgal-pp50dN202 was exclusively localized to the nu-
leus (Fig. 4B). However, deletion of pp50 sequences
eyond residue 395 from the chimeric protein effectively
FIG. 2. Subcellular location of pp50 and N-terminal deletion mutants.
alb/3T3 fibroblasts infected with MCMV (A) were processed for im-
unofluorescence 20 h p.i. as described under Materials and Methods.
imilarly, immunofluorescence microscopy was carried out with COS-1
ells grown on glass coverslips and transfected with plasmids
SVpp50 (B), pSVpp50dN27 (C), pSVpp50dN202 (D), pSVpp50[27–395]
E), and pSVpp50[202–395] (F). The subcellular locations of wild-type
p50 as well as N-terminal deletion mutants were identified by staining
ith MAb 3B9 48 h after transfection.bolished nuclear localization (bgal-pp50[202–395] in mig. 4C), suggesting that the C-terminal 16 amino acids of
p50 may be part of a nuclear localization signal that
ould mediate the nuclear import of the b-galactosidase
usion protein. This hypothesis is further strengthened by
esults showing that the last 11 amino acids of pp50,
hich include the highly conserved cluster of basic
mino acids ‘‘KKQK’’ (Fig. 7A, first line), can direct nuclear
mport when fused in frame to the C terminus of b-ga-
actosidase (bgal-pp50dN401 in Fig. 4D) and constitute a
ikely candidate for the NLS of pp50.
ubcellular location of pp50 C-terminal deletion
utants
We reasoned that if the C-terminal NLS described
bove is solely responsible for the nuclear localization of
p50, progressive deletion from that end of the molecule
hould result in a protein that fails to localize to the
ucleus. The results of experiments using these mutants
re summarized in Fig. 1, and staining patterns of se-
ected C-terminal deletion mutants are shown in Fig. 5.
Our data indicate that stepwise deletions of the hydro-
hilic C-terminal tail of pp50 did not significantly affect
uclear localization (dC395 in Fig. 5A and dC296 in Fig.
B). As illustrated in Fig. 1, sequences including the
KQK motif described in the previous section were de-
eted in dC395. The conserved Region 4 was deleted in
C367. Further deletions removing virtually the entire
-terminal tail, including conserved Regions 3 and 4,
roduced dC296. In each instance, the subcellular loca-
ion as detected by immunofluorescence was predomi-
antly nuclear with faint cytoplasmic staining being ob-
erved only occasionally. Even in dC280 where four
mino acids at the C-terminal end of conserved Region 2
ere deleted, a similar staining pattern was observed
data not shown). However, further deletions into Region
severely impaired nuclear localization, and a bright,
ranular, cytoplasmic fluorescence pattern together with
aint, diffuse nuclear staining was observed when trans-
ected cells were stained with MAb 31E11 (mutant dC266
n Fig. 5C). This suggested that sequences between
esidues 267 and 280, which do not contain clusters of
asic amino acids, probably include amino acids in-
olved in protein folding. Removal of these residues
ould result in conformational changes and affect nu-
lear localization indirectly. When Region 2 was removed
y further deletions, the resulting truncated protein was
ound to be entirely resident in the cytoplasm with bright,
ranular cytoplasmic staining (mutant dC158 in Fig. 5D).
hus it would appear that the putative C-terminal NLS of
p50 may not be the only factor affecting nuclear local-
zation of this protein. Additional determinants within the
-terminal half of the molecule, and Region 2 in partic-
lar, may influence the subcellular localization of pp50
utants.
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48 LOH, KEELER, AND SHANLEYhe conserved N-terminal portion of pp50 cannot
irect nuclear import of a b-galactosidase fusion
rotein
To determine whether the N-terminal sequences of
p50 contain a functional NLS, chimeras containing N-
erminal sequences of pp50 fused in frame to the N-
erminal end (pp50dC296-bgal) or C-terminal end (bgal-
p50dC296 and bgal-pp50dC266) of b-galactosidase se-
uences were constructed. The deletion mutant dC296
as chosen because it contains intact Regions 1 and 2
nd is clearly localized to the nucleus in the absence of
functional C-terminal NLS (Fig. 5B). Fusion to the N-
FIG. 3. Construction of b-galactosidase-pp50 chimeric proteins. Open
p50 sequences. The numbers above each bar are b-galactosidase res
irst 10 amino acids for b-galactosidase have been replaced by the s
loning purposes. The residues found at the end of the C-terminal trun
xpression vector. The extraneous residues RHASWDP found between
f inserting viral DNA between the NcoI and SmaI sites of the b-galac
y indirect immunofluorescence 48 h after transfecting COS-1 cells w
ocations are the same as those used in Fig. 1.erminal end of b-galactosidase (pp50dC296-bgal) could le viewed as replacing the C-terminal tail of pp50 with
oreign sequences and might be less disruptive to pro-
ein folding with respect to pp50. Fusion to the C-terminal
nd of b-galactosidase (bgal-pp50dC296) created a chi-
era that is more comparable to constructs used in
haracterizing the C-terminal NLS (Fig. 3). Parallel exper-
ments using b-galactosidase fusions with the mutant
C266, which is primarily localized to the cytoplasm (Fig.
C), would be used for comparison. The structures and
ubcellular locations of these fusion proteins are sum-
arized in Fig. 3, bottom three lines.
As seen in Fig. 6, fusion proteins consisting of b-ga-
epresent b-galactosidase sequences, whereas shaded bars represent
mbers, whereas those below each bar are pp50 residue numbers. The
e MARDP, providing unique restriction sites (NcoI, BamHI, SmaI) for
p50 sequences are the result of universal stop codons present in the
0 and b-galactosidase sequences in SVpp50dC296-bgal are the result
e gene. Subcellular locations of the fusion proteins were determined
appropriate plasmids. Abbreviations used for describing subcellularbars r
idue nu
equenc
cated p
the pp5
tosidas
ith theactosidase sequences fused with N-terminal sequences
o
p
s
n
p
N
p
N
L
a
d
w
t
c
c
d
o
l
e
o
c
c
c
p
l
s
c
m
s
e
a
b
C
a
t
C
t
v
t
e
a
p
p
o
C
m
a
l
m
3
49NUCLEAR LOCALIZATION IN pp50 SEQUENCESf pp50 were predominantly resident in the cytoplasm. In
articular, the b-galactosidase-pp50 chimeras were
een in globular structures accumulating outside the
ucleus. Thus our results indicated that the N-terminal
ortion of pp50 probably does not contain a functional
LS. Alternatively, structural constraints of the fusion
roteins may prevent the surface exposure of a putative
-terminal NLS.
ysine residues at the extreme C terminus constitute
n essential element of the nuclear localization signal
One of the shortcomings of using N- or C-terminal
eletion mutants is that amino acids unrelated to the
FIG. 4. The C terminus of pp50 contains a nuclear localization signal.
-terminal sequences of pp50 were fused in frame with the b-galac-
osidase ORF and placed behind the SV40 promoter in the plasmid
ector pM2. The ability of pp50 sequences to direct the fusion protein
o the nuclei of COS-1 cells transfected with these plasmids was
valuated by indirect immunofluorescence with a commercially avail-
ble MAb specific for b-galactosidase. The plasmids used were
SVbgal (A), pSVbgal-pp50dN202 (B), pSVbgal-pp50[202–395] (C), and
SVbgal-pp50dN401 (D). DAPI staining was used to visualize the nucleibf transfected cells.ild-type gene product are almost inevitably added to
he mutant as a result of providing translation start
odons or universal termination codons to these trun-
ated coding sequences. Although in our case, the ad-
itional amino acid sequences did not include stretches
f basic amino acids that could affect the subcellular
ocalization of the deletion mutants (Fig. 1), the possibility
xisted that these extraneous sequences may influence
ur results in a more subtle manner. For example,
harged residues or amino acids with aromatic side
hains could participate in protein folding and alter the
onformation of the molecule. Therefore to define more
recisely amino acid residues that affect pp50 nuclear
ocalization, we carried out site-directed mutagenesis of
elected pairs of amino acids and determined the sub-
ellular locations of these site-specific mutants by im-
unofluorescence microscopy. The results of these
tudies and the structures of the mutants used in these
xperiments are summarized in Fig. 7A.
Having already demonstrated that the C-terminal 11
mino acids of pp50 constitute a functional NLS, we
egan by substituting the two lysine residues in the
-terminal KKQK motif with two alanine residues, cre-
ting the KK405AA mutant. Not surprisingly, this mu-
ant is predominantly located in the nucleus (Fig. 8B)
FIG. 5. Subcellular location of pp50 C-terminal deletion mutants.
OS-1 cells grown on glass coverslips were transfected with plas-
ids pSVpp50dC395 (A), pSVpp50dC296 (B), pSVpp50dC266 (C),
nd pSVpp50dC158 (D) and processed for immunofluorescence 48 h
ater. The subcellular locations of the pp50 C-terminal deletion
utants were visualized by staining with MAbs 3B9 (A and B) and
1E11 (C and D).ecause we have already demonstrated that deletion
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50 LOH, KEELER, AND SHANLEYf the last 16 amino acids of pp50 did not abolish
uclear localization (dC395 in Fig. 5A). In contrast, the
N202-KK405AA mutant, in which the same lysine res-
dues in the mutant dN202 were mutated, was detect-
ble only in the cytoplasm (Fig. 8A), implying that
hese two basic residues are indeed an essential
lement of a NLS at the C terminus of pp50. A com-
arison between the mutants KK405AA and dN202-
K405AA suggests that additional determinants within
he first 201 amino acids of pp50, representing the
-terminal amino acid sequences present in the
K405AA mutant but not in dN202-KK405AA, may in-
luence the nuclear localization of pp50. By introducing
he same KK to AA substitutions into N-terminal dele-
ion mutants, we found that dN27-KK405AA was the
utant with the smallest N-terminal deletion that still
ailed to localize to the nucleus (Fig. 8C), suggesting
hat determinants present within the first 26 amino
cids of the protein could affect nuclear localization in
FIG. 6. The conserved N-terminal portion of pp50 cannot direct
uclear import of a b-galactosidase fusion protein. N-terminal se-
uences of pp50 were fused in frame with the b-galactosidase ORF
nd placed behind the SV40 promoter in the plasmid vector pM2. The
bility of pp50 sequences to direct the fusion protein to the nuclei of
OS-1 cells transfected with these plasmids was evaluated by indirect
mmunofluorescence with a commercially available MAb specific for
-galactosidase. The plasmids used were pSVbgal-pp50dC296 (A),
SVpp50dC296-bgal (B), and pSVbgal-pp50dC266 (C). DAPI staining
as used to visualize the nuclei of transfected cells.he absence of a functional C-terminal NLS. iffect of mutations within the first 26 amino acids at
he N terminus on nuclear localization
We considered two possibilities when residues within
he first 26 amino acids of pp50 were selected for mu-
agenesis. First, the presence of a minor NLS could
irect the import of a C-terminal truncated pp50 to the
ucleus in the absence of the KKQK motif at the C
erminus. In this scenario, the RKVR sequence starting at
esidue 5 constitutes the longest stretch of basic amino
cids within the first 26 amino acids as well as con-
erved Region 1 and could potentially be a key element
n a N-terminal NLS. This hypothesis could be tested by
utagenesis of the RK residues. Second, specific amino
cid residues within that region could be essential for
he proper folding of the protein and indirectly influence
uclear localization. We have selected the PP and YK
esidues starting at positions 12 and 22, respectively, for
utagenesis because prolines, charged residues, and
mino acids with aromatic side chains such as tyrosines
re often important determinants of protein structure.
urthermore, all three pairs of our targeted amino acids
RK, PP, and YK) are conserved between MCMV pp50
nd HCMV ppUL44 (Fig. 7A). Thus double mutants in
hich RK, PP, or YK residues of the KK405AA mutant
ere substituted with SS, GA, or TG residues, respec-
ively, were constructed. The structures of these mutants
re shown in Fig. 7A.
As shown in Fig. 8D, the double mutant RK5SS-
K405AA was detectable exclusively in nuclei of trans-
ected cells, implying that the R and K residues at posi-
ions 5 and 6 are not likely to be part of a NLS. The
ubcellular location of the double mutant PP12GA-
K405AA was predominantly nuclear although faint cy-
oplasmic staining was observed in a significant percent-
ge of positive cells (Fig. 8E). Finally, the double mutant
K22TG-KK405AA appeared to be evenly distributed be-
ween the nucleus and cytoplasm of transfected cells
Fig. 8F). Thus the Y or K residues, or both residues
ogether, could conceivably influence nuclear localiza-
ion by affecting proper protein folding.
ffect of internal deletions within the conserved
-terminal domain on nuclear localization
The pair of YK residues at position 22–23 and the
mino acids around them do not have the characteristics
f a ‘‘classical’’ NLS. Therefore it is probable that the
bserved changes in subcellular localization are the
esult of conformational changes of the protein induced
y their substitution with TG residues. We reasoned that
nternal deletions within the highly conserved N-terminal
alf of the protein with the potential of perturbing the
table conformation of pp50 would also influence its
ubcellular localization in a similar manner. For example,f amino acids interacting with the YK residues at posi-
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51NUCLEAR LOCALIZATION IN pp50 SEQUENCESion 22–23 were deleted, the mutant would likely be
mpaired in nuclear import. To this end, mutants d157–
01 and d267–283 were constructed with or without the
K405AA mutations, and their subcellular locations in
ransfected cells were determined by immunofluores-
ence microscopy. The structures of the four mutants are
FIG. 7. Construction of site-specific pp50 mutants. (A) The first 25 and
cid substitutions are shown for each mutant used in this study. Mu
ethods section. For deletion mutants (last four lines), numbers above
roteins were determined by indirect immunofluorescence 48 h after tr
escribing subcellular locations are the same as those in Fig. 1. (B) Am
sequence deleted in d267–183). In all three panels, amino acids that a
hereas amino acids conserved only between MCMV and HCMV are
he first and last amino acids shown.llustrated in Figs. 1 and 7A, and the internal sequences aeleted from these mutants are shown in Figs. 7B and
C.
These particular deletions were selected for initial
nalysis based on the following observations. First, res-
dues 157–201 represent a relatively hydrophilic stretch
f amino acids linking the more hydrophobic regions 1
amino acids of pp50 are shown on the first line. Specific pairs of amino
re labeled according to the scheme described under Materials and
es represent pp50 residue numbers. Subcellular locations of mutant
ing COS-1 cells with the appropriate plasmids. Abbreviations used for
ds 157–201 (sequence deleted in d157–201). (C) Amino acids 267–283
served among MCMV, HCMV, and HHV-6 are marked (1) underneath,
(*) above. Numbers above each sequence represent the positions oflast 22
tants a
the lin
ansfect
ino aci
re con
markednd 2 (Loh et al., 1994). Therefore it could function as a
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52 LOH, KEELER, AND SHANLEY‘linker’’ separating two independently folding and prob-
bly interacting domains. In the HSV-1 UL42 protein,
nsertion mutagenesis of a similar linker sequence abol-
shed DNA polymerase binding and processivity (Digard
t al., 1993). Similarly, deletion of this stretch of amino
cids may disrupt potential interactions between con-
erved Regions 1 and 2 by altering the distance sepa-
ating the two domains. Second, our studies on C-termi-
al deletion mutants have already demonstrated that the
oss of sequences between residues 267 and 280 se-
erely impaired nuclear localization, possibly as a result
f changes in protein conformation (compare dC266 and
C280 in Fig. 1).
The subcellular location of mutant d157–201 as deter-
ined by immunofluorescence microscopy was charac-
erized by bright granular cytoplasmic staining as well as
eak, diffuse nuclear staining and bright nuclear spots
Fig. 9A). Incorporation of the KK405AA mutations com-
letely abolished nuclear localization (Fig. 9B). In con-
rast, the mutant d267–283 was resident entirely in the
uclei of transfected cells (Fig. 9C). Incorporation of the
K405AA mutations significantly impaired nuclear local-
zation, showing a granular cytoplasmic staining pattern
lus diffuse nuclear staining (Fig. 9D).
Thus the deletion of amino acids 157–201 alone is
FIG. 8. Identification of amino acid residues affecting nuclear local-
zation. COS-1 cells transfected with plasmids encoding pp50 carrying
ite-specific mutations were processed for immunofluorescence exper-
ments 48 h after transfection. The plasmids used were pSVpp50dN202-
K405AA (A), pSVpp50-KK405AA (B), pSVpp50dN27-KK405AA (C), pS-
pp50-RK5SS-KK405AA (D), pSVpp50-PP12GA-KK405AA (E), and pS-
pp50-YK22TG-KK405AA (F). The subcellular locations of pp50 mutants
ere visualized by staining with MAb 3B9.ufficient to impair nuclear localization. It is conceivable phat the loss of these residues may introduce global
onformational changes such that surface exposure of
istal sequences like the C-terminal NLS is affected. In
ontrast, the deletion of amino acids 267–283 alone has
ittle observable effect on nuclear localization (Fig. 9C).
erhaps the loss of these residues introduces conforma-
ional changes only within the N-terminal portion of pp50,
esulting in the ‘‘masking’’ of a putative N-terminal NLS or
he loss of association with cellular proteins that could
acilitate the nuclear import of pp50. In that sense, the
utant d267–283 is similar to dN27 (Figs. 1 and 2C) in
hat the effect of the deletion is only obvious when the
-terminal NLS is nonfunctional.
ubcellular locations of pp50 mutants in a
accinia/T7 expression system
One of the pathways for nuclear localization we have
ot considered thus far is passive diffusion into and
etention in the nucleus through interactions with nuclear
omponents. Because pp50 is a DNA-binding protein, it
s conceivable that mutations affecting the dimerization
ut not DNA-binding properties of the protein could allow
he monomeric form of pp50 to diffuse into the nucleus
nd be retained there by binding to cellular DNA. This
ypothesis may account for the previously observed nu-
lear localization of mutants dC395, dC296, and
FIG. 9. Effect of internal deletions on the nuclear localization of
p50.COS-1 cells transfected with plasmids encoding pp50 carrying
nternal deletions within the highly conserved N-terminal domains were
rocessed for immunofluorescence with MAb 3B9 48 h after transfec-
ion. The plasmids used in these experiments were pSVpp50d157–201
A), pSVpp50[d157–201]-KK405AA (B), pSVpp50d267–283 (C), and
SVpp50[d267–283]-KK405AA (D).
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53NUCLEAR LOCALIZATION IN pp50 SEQUENCESp50KK405AA (Figs. 5A, 5B, and 8B), which have clearly
ost their C-terminal NLS. We can test this possibility
ndirectly by making use of the fact that vaccinia virus
NA replication takes place in the cytoplasm (Harford et
l., 1966), thereby allowing the cytoplasmic accumulation
f viral DNA. Because passive diffusion into the nucleus
s likely an inefficient process compared with active
ransport, mutant pp50 molecules without a functional
LS but ,60,000 would be expected to at least partially
ocalize to cytoplasmic sites of vaccinia DNA replication
f their DNA-binding domain is intact. In contrast, pp50
olecules with a functional NLS would continue to be
ctively transported into the nucleus, showing the same
ubcellular distribution in the presence or absence of
accinia virus infection. To this end, CV-1 cells were
ransfected with plasmids encoding various pp50 mu-
ants under the control of the T7 promoter and subse-
uently infected with VV-T7 as described under Materials
nd Methods. The cells were then processed for indirect
mmunofluorescence with pp50-specific MAbs as de-
cribed in the legend for Fig. 10.
As shown in Fig. 10, the expected presence of viral
NA in the cytoplasm was confirmed by DAPI staining of
accinia-infected cells, where, in addition to the usual
FIG. 10. Subcellular locations of pp50 mutants in a vaccinia/T7 expr
nd mutant pp50 ORFs under the control of the bacteriophage T7 prom
mmunofluorescence (IF) with MAb 3B9 (A, B, and D–F) or 9A5 (C). T
p50dC296 (C), pp50KK405AA (D), pp50d267–283 (E), and pp50d157–2ntense staining in the nucleus, fainter cytoplasmic stain- wng was observed. Indirect immunofluorescence with
p50-specific MAbs revealed that wt pp50 was resident
xclusively in the nuclei of vaccinia-infected cells. How-
ver, when the C-terminal NLS was rendered nonfunc-
ional either by deletion (mutants dC395 and dC296 in
igs. 10B and 10C) or mutation of critical lysine residues
mutant pp50KK405AA in Fig. 10D), the mutant proteins
ere almost entirely resident in the cytoplasm. Exami-
ation of the subcellular distribution of these pp50 mu-
ants revealed that their staining pattern roughly over-
apped with the cytoplasmic DAPI staining, suggesting
heir colocalization with vaccinia DNA. Because these
p50 mutants possess intact N-terminal domains re-
uired for DNA-binding (Loh et al., manuscript in prepa-
ation), these observations lend support to our previously
tated hypothesis that the DNA-binding properties of
p50 mutants could influence their subcellular distribu-
ion. In contrast, pp50 mutants that have lost their DNA-
inding ability as a result of deletions within the con-
erved N-terminal domains (pp50d267–283 and
p50d157–201 in Figs. 10E and 10F) showed similar
ubcellular distributions in the absence (Figs. 9A and 9C)
r presence of vaccinia virus infection. In particular, the
ytoplasmic distribution of pp50d157–201 did not overlap
system. CV-1 cells transfected with plasmids encoding wild-type (wt)
re infected with VV-T7 4 h after transfection and processed for indirect
s expressed in the different panels are wt pp50 (A), pp50dC395 (B),ession
oter we
he ORFith the cytoplasmic DAPI staining. It should be noted
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54 LOH, KEELER, AND SHANLEYhat both these mutants contain intact C-terminal NLSs
nd are expected to be actively transported into the
ucleus if the C-terminal NLS is functional.
In summary, our data on the subcellular distribution of
p50 mutants in the vaccinia/T7 expression system and
n conventional transfection experiments lend support to
ur hypothesis that the C-terminal NLS is the major
eterminant for the nuclear localization of pp50. How-
ver, in the absence of the C-terminal NLS, the DNA-
inding and dimerization properties of mutant pp50 mol-
cules may influence their subcellular localization by
ediating retention in the cytoplasm or the nucleus de-
ending on the presence of sufficient DNA in either
ocation.
DISCUSSION
In this report, we have investigated the sequence
equirements for the nuclear localization of MCMV pp50,
ene product of the M44 ORF. Computer-aided analysis
f the ORF revealed three isolated stretches of basic
mino acids that are likely to be exposed on the surface
f the protein: (1) ‘‘RKVR,’’ starting at residue 5 (Fig. 7A,
irst line); (2) ‘‘KRNSKK,’’ starting at residue 169 within a
ydrophilic stretch of amino acids between Regions 1
nd 2 (Fig. 7B); and (3) ‘‘KKQK,’’ starting at residue 405
ithin Region 4 at the extreme C terminus of pp50 (Fig.
A, first line). Based on this information, we hypothesized
hat the KKQK motif would constitute the most likely
andidate for a NLS especially because a highly con-
erved casein kinase II phosphorylation site is nearby,
urther enhancing its similarity to the prototypical SV40
-antigen NLS.
Subcellular localization experiments with our series of
- and C-terminal deletion mutants clearly supported
his hypothesis (Fig. 1). Removal of the first basic cluster
KVR in dN27 and further deletion of the second basic
luster in dN202 produced gene products that were
xclusively resident in the nuclei of transfected cells
Figs. 2C and 2D). Nuclear localization of dN27 or dN202
as abolished either by deletion of the last 16 amino
cids of the ORF (mutants pp50[27–395] and pp50[202–
95], Figs. 2E, 2F, and 3) or, more significantly, by the
ubstitution of a pair of lysine residues at position 405–
06 with alanines (mutants dN27-KK405AA and dN202-
K405AA, Figs. 7A, 8A, and 8C). Our hypothesis was
urther strengthened by results from our experiments
ith b-galactosidase-pp50 fusion proteins where dele-
ion of the last 16 amino acids of pp50 abolished nuclear
ocalization of the chimeric protein (Figs. 3, 4B, and 4C),
nd the presence of the last 11 amino acids alone was
ufficient to mediate nuclear import of the fusion protein
gal-pp50dN401 (Figs. 3 and 4D). Thus we concluded
hat the last 11 amino acids of pp50, which contain a
KQK motif, constitute a functional NLS, and the pair of aysines within that motif is an important element of the
-terminal NLS. Furthermore we have demonstrated the
bsolute requirement of a functional C-terminal NLS for
uclear localization even if the truncated pp50 is small
nough to passively diffuse into the nucleus (compare
utants dN202, [202–395] and dN202–KK405AA in Figs.
D, 2F, and 8A).
Our hypothesis of a single C-terminal NLS was com-
licated by the observation that neither the substitution
f the lysines at position 405 with alanines nor the
eletion of the last 16 amino acids significantly affected
uclear localization if the highly conserved N-terminal
wo-thirds of the molecule remained intact (mutant
K405AA in Fig. 8B and mutant dC395 in Fig. 5A). There-
ore it is likely that the putative C-terminal NLS functions
ogether with additional determinants within the N-
erminal domains of pp50 to mediate active transport of
he protein into the nucleus. By introducing the KK405AA
utations into N-terminal deletion mutants as well as
nternal deletion mutants to inactivate the C-terminal
LS, we were able to identify three sets of N-terminal
equences that might play a role in nuclear localization
n the absence of a functional C-terminal NLS. These
equences are: (1) the first 26 amino acids of pp50
mutant dN27-KK405AA in Fig. 8C); (2) amino acids 157–
01 located between Regions 1 and 2 (mutant [d157–
01]-KK405AA in Fig. 9B); and (3) amino acids 267–283 at
he C-terminal end of Region 2 (mutant [d267–283]-
K405AA in Fig. 9D).
Examination of these N-terminal sequences led us
o speculate on their possible influences on nuclear
ocalization. First, the presence of additional nuclear
ocalization signals within these sequences could me-
iate nuclear import in the absence of the C-terminal
LS. For example, the tumor suppressor p53 is known
o possess multiple NLSs within its coding sequences
Shaulsky et al., 1990). Examination of the three sets of
-terminal sequences of pp50 described in the previ-
us paragraph led to the following conclusions. There
re no significant stretches of basic amino acids be-
ween residues 267 and 283 of the pp50 ORF. It is also
nlikely that the RKVR sequence (positions 5–8) within
he first 26 amino acids would function as a NLS
ecause substitution of the RK residues with serines
id not affect nuclear localization in the absence of a
unctional C-terminal NLS (mutant RK5SS-KK405AA in
ig. 8D). On the other hand, deletion of residues 157–
01, which contains a stretch of basic amino acids
RNSKK, significantly impaired nuclear localization in
he presence of an intact C-terminal NLS (mutant
157–201 in Figs. 9A and 10F) and completely abol-
shed nuclear localization in the absence of a func-
ional C-terminal NLS (mutant [d157–201]-KK405AA in
ig. 9B). Thus our data did not exclude the existence of
second NLS located between residues 157 and 201.
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55NUCLEAR LOCALIZATION IN pp50 SEQUENCESowever, it should be noted that the intact N-terminal
omain of pp50 cannot direct the nuclear import of a
-galactosidase-pp50 fusion protein (Fig. 6), making it
uite unlikely that a NLS exists within this portion of
he molecule. Nevertheless, it is possible that our
ailure to observe nuclear localization of the chimeric
roteins may be the result of structural constraints
ntroduced when the N-terminal sequences of pp50
re fused with a much larger protein like b-galactosi-
ase, especially in view of the demonstrated sensitiv-
ty of the putative N-terminal NLS to small deletions at
he N-terminal end (amino acids 1–26) or C-terminal
nd (amino acids 267–283) of this highly conserved
ection of the molecule. Therefore, to resolve the
uestion of whether a N-terminal NLS exists, future
xperiments should be directed toward investigating
he effect of mutating the basic residues within the
RNSKK sequence on nuclear localization.
A second possibility that may be applicable to all three
ets of N-terminal sequences is that specific amino ac-
ds within these sequences may be essential for main-
aining a proper and stable conformation of the molecule
uch that the C-terminal NLS is available for interaction
ith the importin heterodimer. For example, it has been
ypothesized that deletion of sequences within the N
erminus of HSV-1 ICP8 might alter the conformation of
he protein and affect nuclear localization even though
he C-terminal NLS was intact (Gao and Knipes, 1992). In
nother example, disruption of an alpha helix at the N
erminus of HIV Vpr was sufficient to impair nuclear
ocalization (Yao et al., 1995). In our site-directed mu-
agenesis experiments designed to examine the effect of
mino acid substitutions within the first 26 amino acids
f pp50, the YK-to-TG mutations at residues 22 and 23
ad the most significant effect on nuclear localization
mutant YK22TG-KK405AA in Fig.e 8F), followed by the
ore subtle effect seen with the PP-to-GA substitutions
t residues 12 and 13 (mutant PP12GA-KK405AA in Fig.
E). It is conceivable that the PP to GA substitutions may
lter the rigid turns imposed by two consecutive prolines
o a more flexible and perhaps less stable structure. In
ontrast, the Y-to-T substitution preserves the hydroxyl
roup but removes the aromatic ring structure, which
ould play a role in stabilizing protein folding via inter-
ctions with other aromatic and/or hydrophobic resi-
ues. Furthermore the K-to-G substitution could disrupt
nteractions with other negatively charged residues (e.g.,
arboxyl groups) and/or increase local flexibility. Thus
oth pairs of amino acid substitutions could potentially
nduce conformational changes in the protein and hence
lter its subcellular location by affecting the surface
xposure of putative nuclear localization signals. Simi-
arly, the other two deleted sequences (residues 157–201
nd 267–283 in Figs. 7B and 7C) also contain highly
onserved prolines (residues 164, 190, and 191) and amino acids with aromatic side chains (tryptophan at
esidue 161, and phenylalanines at residues 195, 268,
nd 281) that could be important determinants in ensur-
ng correct protein folding. As a result of the loss of one
r more of these amino acids, the putative N-terminal
LS (probably the KRNSKK sequence at positions 169–
74) may no longer be accessible for binding to the
mportin heterodimer. The effect of deleting amino acids
57–201 is particularly severe in that the mutant d157–
01 is impaired in nuclear localization (Fig. 9A) even with
n intact C-terminal NLS. It is conceivable that proper
olding of the pp50 molecule requires specific interac-
ions between the two highly conserved Regions 1 and 2,
nd removal of the linking sequence (residues 157–201)
ould alter the critical spacing between the two domains,
esulting in a grossly misfolded protein and the masking
f the C-terminal NLS.
Third, conformational changes induced in the N-termi-
al domains as a result of mutations described above
ould lead to the disruption of other biochemical prop-
rties of pp50 that might influence nuclear localization.
or example, results from other experiments conducted
n this laboratory suggested that both dimerization and
he DNA-binding properties of pp50 may be affected by
eletions into or within the highly conserved N-terminal
omains (Loh et al., manuscript in preparation). In the
bsence of a C-terminal NLS, monomeric pp50 mutants
esulting from defects in dimerization or some of the
ore heavily truncated pp50 mutants under the 60,000
ize limit could passively diffuse into and be retained in
he nucleus by binding to cellular DNA if the N-terminal
NA-binding domain is intact (e.g., mutants dC395,
C296, and pp50KK405AA in Figs. 5A, 5B, and 8B). This
onjecture is reinforced by results from subcellular lo-
alization experiments in the presence of vaccinia virus
nfection where nuclear import of these mutants was
locked in the presence of vaccinia virus infection. The
bserved cytoplasmic location of these mutants under
uch circumstances could be explained if the newly
ynthesized mutant proteins were retained at sites of
iral DNA replication in the cytoplasm before they could
iffuse into the nucleus as a result of their intact DNA-
inding domains (Figs. 10B–10D). On the other hand,
egardless of whether their sizes are above or below the
assive diffusion limit, mutants that are defective in DNA-
inding can only localize to the nucleus if they possess
functional C-terminal NLS (mutants dN27, dN202, and
267–283 with and without functional C-terminal NLSs,
igs. 2, 8, and 9). Otherwise, they remain resident in the
ytoplasm.
Last, the possibility exists that improper folding could
mpair specific interactions with other cellular proteins
hat possess NLSs and prevent nuclear import of pp50
s part of a protein complex. Such protein–protein inter-
ctions might explain why pp50 mutants lacking the
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56 LOH, KEELER, AND SHANLEY-terminal NLS could enter the nucleus even if their
izes are .60,000. We have not explored this aspect in
epth because the identity of cellular proteins that can
ssociate with pp50 is unknown.
In summary, our results suggested that the nuclear
ocalization of pp50 depends on three factors: (1) the
resence of the C-terminal NLS centered around the
KQK motif and (2) the structural integrity of the highly
onserved N-terminal half of the protein encompassing
egions 1 and 2, (3) the unlikely but possible existence of
minor N-terminal NLS. The potential influence of bio-
hemical properties such as DNA-binding and dimeriza-
ion on nuclear localization could be important consider-
tions in the construction of pp50 mutants for evaluating
ts role in the virus replication cycle.
MATERIALS AND METHODS
ells and DNA transfections
COS-1 and CV-1 cells used in the transfection exper-
ments were maintained in Dulbecco’s minimum essen-
ial media (DMEM) supplemented with 10% fetal bovine
erum. Transfection of plasmid DNA into COS-1 cells
as carried out by electroporation as previously de-
cribed (Loh et al., 1994). Cells were harvested 48 h
osttranfection for indirect immunofluorescence experi-
ents or solubilized in immunoprecipitation buffer (Tris-
uffered saline pH 8, supplemented with 1% NP-40, 1%
eoxycholate, and 1 mM phenylmethylsulfonyl fluoride),
nd clarified by centrifugation in a microfuge for 20 min
t 15,000 g in preparation for Western-blotting experi-
ents.
The vaccinia/T7 expression system described by Fu-
rst et al., (1986) was also used as a transient expression
ystem for determining the subcellular location of wt or
utant pp50 proteins. Briefly, CV-1 or COS-1 cells were
ransfected with plasmid DNA containing wt or mutant
p50 ORFs under the control of the bacteriophage T7
romoter. Transfected cells were allowed to attach to
issue culture plates for 4 h before infection with VV-T7
recombinant vaccinia virus stably expressing the T7
NA polymerase, a gift from Dr. William Britt, University
f Alabama) at a m.o.i. of 5. Infected cells were harvested
day later for immunofluorescence or Western-blotting
xperiments.
onoclonal antibodies
Monoclonal antibodies (MAbs) were prepared as pre-
iously described (Chang and Balachandran, 1991; Loh
t al., 1991; Pande et al., 1991). In particular, MAb 9A5
as raised against HHV-6 p41 but was cross-reactive
ith determinants present on MCMV pp50 (Loh et al.,
994). Monoclonal antibodies 3B9, 5H10, 25G11, 33C7,
nd 31E11 were specific for MCMV pp50 (Loh et al., 1991; vande et al., 1991; unpublished results from J. Shanley’s
aboratory). A monoclonal antibody against b-galactosi-
ase was purchased from Gibco/BRL.
ndirect immunofluorescence
COS-1 cells transfected with DNA were grown on
ight-well chamber slides (Gibco/BRL, Canada) or glass
overslips for 48 h before they were fixed in methanol
nd acetone at 220°C. Alternatively, cells on coverslips
ere fixed in 3.75% formaldehyde for 5 min and perme-
bilized by a 5-min incubation with phosphate-buffered
aline (PBS) supplemented with 1% Triton X-100. The
ubcellular location of mutant pp50 was determined by
taining with appropriate MAbs, and the nuclei of trans-
ected cells were visualized by incubation with the fluo-
escent DNA-binding dye 49,6-diamidino-2-phenylindole
DAPI, 1 mg/ml in a solution consisting of 50% glycerol
nd p-phenylene diamine at 1 mg/ml). In typical trans-
ection experiments, 30–50% of the cells would be posi-
ive for expression of the protein encoded by the plasmid
nd representative photographs were taken with Tmax
00 film (Kodak).
el electrophoresis and Western blotting
SDS–polyacrylamide gel electrophoresis (SDS–PAGE)
nd detection of mutant forms of pp50 by Western blot-
ing were carried out as described in Loh et al., (1991)
sing monoclonal antibodies described in a previous
ection.
omenclature for deletion and site-specific mutants
We have adopted a labelling scheme similar to that
sed by Digard et al. (1993). N-terminal deletion mutants
nd C-terminal deletion mutants were labeled dNX or
CX, respectively, where X refers to the first pp50-spe-
ific amino acid present after the deletion. Internal dele-
ion mutants are labeled dX-Y when an amino acid se-
uence beginning with residue X and ending with resi-
ue Y is deleted. Site-specific mutants involving
ubstitution of two consecutive amino acid residues are
escribed as KKXAA if amino acids KK starting at residue
are substituted with amino acids AA. Expression plas-
ids in which these mutant ORFs are placed behind the
V40 promoter would be labeled as pSVpp50[ ] where [ ]
epresents the name of the ORF. For example, an expres-
ion plasmid encoding the mutant dN395 would be
amed pSVpp50dN395.
ite-directed mutagenesis
Site-directed mutagenesis was used to introduce use-
ul restriction sites or specific mutations into the coding
equence of pp50. Both the Muta-Gene Phagemid in
itro mutagenesis kit (Bio-Rad) and the QuikChange Site-
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57NUCLEAR LOCALIZATION IN pp50 SEQUENCESirected mutagenesis kit (Stratagene) were used suc-
essfully for these experiments. In most cases, the mu-
agenesis primers were designed such that the mutated
lasmids could be screened by the presence of new
estriction sites. Subsequently the site-specific muta-
ions introduced were verified by nucleotide sequencing,
nd the size and reactivity of the expressed mutant
rotein with MAbs were confirmed by Western blotting.
ucleotide sequencing of the mutant ORFs has not re-
ealed any adventitious mutations arising elsewhere.
he plasmid pTB16, which contained the intact ORF for
p50 (Loh et al., 1994), was used as the initial template
or site-directed mutagenesis. A unique NcoI site was
ntroduced into the translation start codon of pp50 using
he mutagenesis primer CATCTCCGCGGCCATGGAGG-
TGGT to produce the plasmid pTB16N. This plasmid
as used as the template for the construction of most of
he site-specific mutants used in this study. The pres-
nce of unique NcoI and HindIII sites flanking the pp50
RF facilitated the transfer of mutant ORFs into expres-
ion vectors.
To allow the excision of a 0.31-kb DNA fragment from
TB16N encoding the last 11 amino acids of pp50, site-
irected mutagenesis was used to introduce a unique
coRI site into the pp50 ORF using the mutagenesis
rimer GTGACCTTCGAATTCACTCCCAACACTA. This
ermitted the subsequent construction of plasmid
SVbgal-pp50dN401, which encodes a chimeric protein
onsisting of the C-terminal 11 amino acids of pp50
used to the C terminus of b-galactosidase.
onstruction of site-specific mutants
Mutations introduced into pairs of amino acids within
he pp50 ORF were constructed as follows. The mu-
agenesis primer CACTCCCAACACTGCAGCCCAAAAGT-
CGCGGCCTG was used to construct the mutant pp50-
K405AA where lysine residues at positions 405 and 406
ere substituted with alanine residues as indicated by
he underlined nucleotides. Similarly, the primers GGC-
ATGGAGGGTGGGAGCTCAGTTCGCGAGCACG, CGAG-
ACGAAGGCGCCACCCTGGCCTTTC, and CCTCAAGTCG-
CCGGGACCGCCATCCAGCAG were used to construct
he mutants pp50-RK5SS, pp50-PP12GA, and pp50-
K22TG, respectively. Double mutants were constructed
ither by site-directed mutagenesis of single mutants, or
henever possible, by making use of unique NarI or SphI
ites within the pp50 ORF to join together N- and C-
erminal halves of pp50 coding sequences carrying the
ppropriate mutations. A diagram illustrating the muta-
ions introduced into the pp50 ORF is shown in Fig. 7A.
Expression of site-specific mutants in COS-1 cells was
ccomplished by inserting a 1.6-kb BamHI fragment con-
aining the entire ORF of the pp50 mutant between the
glII-BamHI cloning sites of the plasmid vector pM2, thereby placing the pp50 ORF behind the SV40 early
romoter.
onstruction of pp50 deletion mutants
The plasmid pTB16 was used as the template for the
onstruction of nested sets of N- and C-terminal dele-
ions as previously described (Henikoff, 1987). Appropri-
te choices of restriction enzymes ensured the preferen-
ial deletion into the coding sequences of the pp50 ORF
hile leaving the unique flanking EcoRI and HindIII sites
ntact so that the deletion constructs could be easily
xcised. Briefly, in constructing C-terminal deletion mu-
ants, the plasmid was cleaved with PstI and SmaI before
igestion with Exonuclease III. Similarly, in the construc-
ion of N-terminal deletion mutants, cleavage with KpnI
nd BamHI before Exonuclease III digestion ensured the
referential deletion of coding sequences at the N ter-
inus of pp50. The exact extent of the deletion was
etermined by nucleotide sequencing. For the expres-
ion of C-terminal deletion mutants, the truncated coding
equence was excised by BamHI-HindIII digestion and
nserted into the unique BglII-HindIII sites of the plasmid
ector pM2 (Sadowski et al., 1992), thereby positioning
he SV40 early promoter in front of the translation start
ite and providing a universal translation termination
equence behind the truncated coding sequence. How-
ver, as shown in Fig. 1, extraneous amino acids were
nevitably introduced into the C terminus of the mutants.
n the case of N-terminal deletions, the truncated se-
uence was excised by EcoRI-HindIII digestion and in-
erted in-frame behind the six histidine residues (his-tag)
f pRSET vectors (Invitrogen). The unique NcoI site of the
ector then provided a translation start site immediately
pstream of the truncated pp50 coding sequence. As a
esult, an ORF encoding a N-terminal truncated pp50
rotein without the his-tag could be excised as a BamHI-
indIII fragment and inserted into the pM2 vector as
escribed above. Again, extra amino acids were intro-
uced at the N terminus of the mutants as illustrated in
ig. 1.
Mutant pp50 carrying internal deletions were con-
tructed as follows. Excision of a 135-bp SstI fragment
ithin the coding sequence of pp50 from pTB16N and
eligation produced the plasmid pTB16NdSst. The short-
ned ORF was placed behind the SV40 promoter in pM2
o create the expression plasmid pSVpp50d157–201. Sim-
larly, the plasmid pSVpp50d267–283 was constructed by
nserting a 0.6-kb SphI-HindIII fragment representing the
oding sequence for the hydrophilic C-terminal tail of
p50 in frame behind the C-terminal-truncated ORF
ound in the plasmid pSVpp50dC266.
The predicted sizes of all deletion mutants were con-
irmed by Western blotting. The names of deletion mu-
ants used in epitope-mapping experiments are shown in
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58 LOH, KEELER, AND SHANLEYhe first column of Table 1, whereas the structures of
eletion mutants used in subcellular localization exper-
ments are illustrated in Fig. 1.
onstruction of b-galactosidase fusion proteins
The b-galactosidase gene was modified to facilitate
he construction of fusion proteins. Sequences contain-
ng unique restriction sites (NcoI, BamHI, and SmaI)
eplaced those encoding the first nine amino acids of the
ene. As a result, the first five amino acids of the mod-
fied b-galactosidase in single letter codes are MARDP
Fig. 3), being followed immediately by the 10th amino
cid of authentic b-galactosidase. The chimera
p50dC296-bgal was constructed by inserting the cod-
ng sequence for the mutant dC296 between the NcoI
nd SmaI sites at the 59 end of the b-galactosidase gene.
lternately, a unique EcoRI site located at the extreme 39
nd of the b-galactosidase gene was used for the inser-
ion of DNA fragments to generate chimeric proteins
onsisting of the first 1004 amino acids of b-galactosi-
ase fused in frame with defined segments of pp50. The
ntire ORF of the chimeric protein could then be excised
s a NcoI-HindIII fragment and placed behind the SV40
romoter in the plasmid vector pM2 for expression in
OS-1 cells. The structures of chimeric proteins used in
his study are illustrated in Fig. 3.
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